Chemoradiotherapy versus surgery followed by postoperative radiotherapy in tonsil cancer: Korean Radiation Oncology Group (KROG) study

被引:3
作者
Song, Sanghyuk [1 ]
Wu, Hong-Gyun [2 ]
Lee, Chang Geol [3 ]
Keum, Ki Chang [3 ]
Kim, Mi Sun [3 ]
Ahn, Yong Chan [4 ]
Oh, Dongryul [4 ]
Park, Hyo Jung [4 ]
Lee, Sang-Wook [5 ]
Park, Geumju [5 ]
Moon, Sung Ho [6 ]
Cho, Kwan Ho [6 ]
Kim, Yeon-Sil [7 ]
Won, Yongkyun [7 ]
Oh, Young-Taek [8 ]
Kim, Won-Taek [9 ,10 ]
Jeong, Jae-Uk [11 ]
机构
[1] Kangwon Natl Univ Hosp, Dept Radiat Oncol, Baengnyeong Ro 156, Chunchon 24289, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Radiat Oncol, 101 Daehangno, Seoul 110744, South Korea
[3] Yonsei Canc Ctr, Dept Radiat Oncol, 50-1 Yonsei Ro, Seoul 03722, South Korea
[4] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, 81 Irwon Ro, Seoul 06351, South Korea
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea
[6] Natl Canc Ctr, Res Inst & Hosp, 323 Ilsan Ro, Goyang Si 10408, Gyeonggi Do, South Korea
[7] Catholic Univ Korea, Seoul St Marys Hosp, Dept Radiat Oncol, 222 Banpo Daero, Seoul 06591, South Korea
[8] Ajou Univ, Sch Med, Dept Radiat Oncol, Gyeonggi, South Korea
[9] Pusan Natl Univ Hosp, Dept Radiat Oncol, 179 Gudeok Ro, Busan 49241, South Korea
[10] Pusan Natl Univ, Sch Med, 179 Gudeok Ro, Busan 49241, South Korea
[11] Chonnam Natl Univ, Sch Med, Dept Radiat Oncol, 42 Jebong Ro, Gwangju 61469, South Korea
来源
BMC CANCER | 2017年 / 17卷
基金
新加坡国家研究基金会;
关键词
Tonsil cancer; Chemoradiotherapy; Surgery; Adjuvant radiotherapy; Induction chemotherapy; SQUAMOUS-CELL CARCINOMA; NECK-CANCER; CONCURRENT CHEMORADIOTHERAPY; DEFINITIVE RADIOTHERAPY; OROPHARYNGEAL CANCER; HUMAN-PAPILLOMAVIRUS; PROGNOSTIC-FACTORS; HEAD; THERAPY; SURVIVAL;
D O I
10.1186/s12885-017-3571-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Treatment of tonsil cancer, a subset of oropahryngeal cancer, varies between surgery and radiotherapy. Well-designed studies in tonsil cancer have been rare and it is still controversial which treatment is optimal. This study aimed to assess the outcome and failure patterns in tonsil cancer patients treated with either approaches. Methods: We retrospectively reviewed medical records of 586 patients with tonsil cancer, treated between 1998 and 2010 at 16 hospitals in Korea. Two hundred and one patients received radiotherapy and chemotherapy (CRT), while 385 patients received surgery followed by radiotherapy and/or chemotherapy (SRT). Compared with the SRT group, patients receiving CRT were older, with more advanced T stage and received higher radiotherapy dose given by intensity modulation techniques. Overall survival (OS), disease-free survival (DFS), locoregional recurrence-free survival (LRRFS), distant metastasis-free survival (DMFS), and clinicopathologic factors were analyzed. Results: At follow-up, the 5-year OS, DFS, LRRFS and DMFS rates in the CRT group were 82, 78, 89, and 94%, respectively, and in the SRT group were 81, 73, 87, and 89%, respectively. Old age, current smoking, poor performance status, advanced T stage, nodal involvement, and induction chemotherapy were associated with poor OS. Induction chemotherapy had a negative prognostic impact on OS in both treatment groups (p = 0.001 and p = 0.033 in the CRT and SRT groups, respectively). Conclusions: In our multicenter, retrospective study of tonsil cancer patients, the combined use of radiotherapy and chemotherapy resulted in comparable oncologic outcome to surgery followed by postoperative radiotherapy, despite higher-risk patients having been treated with the definitive radiotherapy. Induction chemotherapy approaches combined with either surgery or definitive radiotherapy were associated with unfavorable outcomes.
引用
收藏
页数:8
相关论文
共 25 条
  • [1] Prognostic factors in oropharyngeal cancer - analysis of 627 cases receiving definitive radiotherapy
    Agarwal, Jai Prakash
    Mallick, Indranil
    Bhutani, Ritu
    Ghosh-Laskar, Sarbani
    Gupta, Tejpal
    Budrukkar, Ashwini
    Murthy, Vedang
    Sengar, Manju
    Dinshaw, Ketayun A.
    [J]. ACTA ONCOLOGICA, 2009, 48 (07) : 1026 - 1033
  • [2] Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
    Ang, K. Kian
    Harris, Jonathan
    Wheeler, Richard
    Weber, Randal
    Rosenthal, David I.
    Nguyen-Tan, Phuc Felix
    Westra, William H.
    Chung, Christine H.
    Jordan, Richard C.
    Lu, Charles
    Kim, Harold
    Axelrod, Rita
    Silverman, C. Craig
    Redmond, Kevin P.
    Gillison, Maura L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (01) : 24 - 35
  • [3] INFLUENCE OF CIGARETTE-SMOKING ON THE EFFICACY OF RADIATION-THERAPY IN HEAD AND NECK-CANCER
    BROWMAN, GP
    WONG, G
    HODSON, I
    SATHYA, J
    RUSSELL, R
    MCALPINE, L
    SKINGLEY, P
    LEVINE, MN
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (03) : 159 - 163
  • [4] Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma
    Calais, G
    Alfonsi, M
    Bardet, E
    Sire, C
    Germain, T
    Bergerot, P
    Rhein, B
    Tortochaux, J
    Oudinot, P
    Bertrand, P
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (24) : 2081 - 2086
  • [5] Results of transoral laser microsurgery in 102 patients with squamous cell carcinoma of the tonsil
    Canis, Martin
    Martin, Alexios
    Kron, Martina
    Konstantinou, Alexandra
    Ihler, Friedrich
    Wolff, Hendrik A.
    Matthias, Christoph
    Steiner, Wolfgang
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2013, 270 (08) : 2299 - 2306
  • [6] Pattern of cervical lymph node metastasis in tonsil cancer: Predictive factor analysis of contralateral and retropharyngeal lymph node metastasis
    Chung, Eun-Jae
    Oh, Jeong-In
    Choi, Kyu-Young
    Lee, Dong-Jin
    Park, Il-Seok
    Kim, Jin-Hwan
    Rho, Young-Soo
    [J]. ORAL ONCOLOGY, 2011, 47 (08) : 758 - 762
  • [7] Oropharyngeal cancer: current understanding and management
    Cohan, David M.
    Popat, Saurin
    Kaplan, Seth E.
    Rigual, Nestor
    Loree, Thom
    Hicks, Wesley L., Jr.
    [J]. CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2009, 17 (02) : 88 - 94
  • [8] Cohen EEW, 2012, J CLIN ONCOL, V30
  • [9] Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck
    Cooper, JS
    Pajak, TF
    Forastiere, AA
    Jacobs, J
    Campbell, BH
    Saxman, SB
    Kish, JA
    Kim, HE
    Cmelak, AJ
    Rotman, M
    Machtay, M
    Ensley, JF
    Chao, KSC
    Schultz, CJ
    Lee, N
    Fu, KK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19) : 1937 - 1944
  • [10] Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
    Haddad, Robert
    O'Neill, Anne
    Rabinowits, Guilherme
    Tishler, Roy
    Khuri, Fadlo
    Adkins, Douglas
    Clark, Joseph
    Sarlis, Nicholas
    Lorch, Jochen
    Beitler, Jonathan J.
    Limaye, Sewanti
    Riley, Sarah
    Posner, Marshall
    [J]. LANCET ONCOLOGY, 2013, 14 (03) : 257 - 264